Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Meredith

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor responseRuby Meredith
Seminars in Nuclear Medicine|July 30, 2008
Risks to normal tissues from radionuclide therapyRuby Meredith, Barry Wessels, Susan Knox
Cancer Biotherapy & Radiopharmaceuticals|January 14, 2012
Predictors of long-term outcome from intraperitoneal radioimmunotherapy for ovarian cancerRuby Meredith, Zhiying You, Ronald Alvarez, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapyJatin J Shah, Ruby Meredith, Sui Shen, et al.
Head & Neck|April 30, 2008
Cancer of the tonsil presenting as central nervous system metastasis: A case reportMichael C Dobelbower, Lisle Nabell, James Markert, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapyRuby Meredith, Sui Shen, Daniel Macey, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2022
ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for TraineesAna P Kiess, Robert F Hobbs, Bryan Bednarz, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion proteinSui Shen, Ruby Meredith, Jun Duan, et al.
Journal of Applied Clinical Medical Physics|February 19, 2009
Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR sourceChang Hyun Choi, Sung-Joon Ye, E Ishmael Parsai, et al.
Head & Neck|January 2, 2003
Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancerSharon Spencer, Richard Wheeler, Glenn Peters, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor responseRuby Meredith
Seminars in Nuclear Medicine|July 30, 2008
Risks to normal tissues from radionuclide therapyRuby Meredith, Barry Wessels, Susan Knox
Cancer Biotherapy & Radiopharmaceuticals|January 14, 2012
Predictors of long-term outcome from intraperitoneal radioimmunotherapy for ovarian cancerRuby Meredith, Zhiying You, Ronald Alvarez, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapyJatin J Shah, Ruby Meredith, Sui Shen, et al.
Head & Neck|April 30, 2008
Cancer of the tonsil presenting as central nervous system metastasis: A case reportMichael C Dobelbower, Lisle Nabell, James Markert, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapyRuby Meredith, Sui Shen, Daniel Macey, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2022
ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for TraineesAna P Kiess, Robert F Hobbs, Bryan Bednarz, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion proteinSui Shen, Ruby Meredith, Jun Duan, et al.
Journal of Applied Clinical Medical Physics|February 19, 2009
Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR sourceChang Hyun Choi, Sung-Joon Ye, E Ishmael Parsai, et al.
Head & Neck|January 2, 2003
Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancerSharon Spencer, Richard Wheeler, Glenn Peters, et al.
Pageof 2